10 companies

Illumina

Market Cap: US$20.6b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

ILMN

US$139.37

7D

8.4%

1Y

78.3%

Exelixis

Market Cap: US$11.1b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

EXEL

US$44.17

7D

-1.1%

1Y

10.9%

ACADIA Pharmaceuticals

Market Cap: US$3.8b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

ACAD

US$22.19

7D

-0.5%

1Y

46.6%

ADMA Biologics

Market Cap: US$2.4b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

ADMA

US$10.31

7D

-5.7%

1Y

-56.5%

Aurinia Pharmaceuticals

Market Cap: US$2.0b

A biopharmaceutical company, engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs in the United States and Japan.

AUPH

US$15.77

7D

-3.7%

1Y

90.9%

Theravance Biopharma

Market Cap: US$864.6m

A biopharmaceutical company, develops and commercializes medicines in the United States.

TBPH

US$16.91

7D

0.6%

1Y

64.3%

CorMedix

Market Cap: US$611.0m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

CRMD

US$7.90

7D

1.0%

1Y

-12.5%

Abeona Therapeutics

Market Cap: US$338.2m

A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.

ABEO

US$5.95

7D

11.0%

1Y

3.4%

Compugen

Market Cap: US$256.2m

A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.

CGEN

US$2.64

7D

-9.6%

1Y

92.7%

Oramed Pharmaceuticals

Market Cap: US$161.0m

Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.

ORMP

US$3.93

7D

-4.4%

1Y

70.1%